PATENT CLAIM ANALYSIS

Application Number: 15780732
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["514", "049000"]

Abstract:
Provided relates to conjugates including cytarabine and an amino acid for use in the treatment of cancer. Further, the subject matter relates to conjugates of cytarabine and aspartic acid for use in the treatment of hematological cancers in medically compromised patients.

Claim (Index 55):
The method of  claim 53 , wherein the pharmaceutically acceptable salt is a salt of an organic or inorganic acid selected from the group consisting of acetic acid, hydrochloric acid, methanesulfonic acid, phosphoric acid, citric acid, lactic acid, succinic acid, tartaric acid, boric acid, benzoic acid, toluenesulfonic acid, benzenesulfonic acid, ascorbic acid, sulfuric acid, maleic acid, formic acid, malonic acid, nicotinic acid and oxalic acid.

Metadata:
- Claim Count in Document: 47.0
- Percentile: 94.0
- Lexical Diversity: 1.57143
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13762238', '12730097', '15277857', '15407122', '12267321']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7117980241618265
- 35 USC 102 Novelty (BERT): 0.5104841112390307
- Combined Prediction Score: 0.6916666328695469
- Mean Citation Score: 262.23539600000004
- Max Citation Score: 271.10385
- Similarity Product: 184.4210249141693

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test